Paraneoplastic pemphigus: A report of three cases including one long-term survivor

Camisa, Charles; Helm, Thomas N.; Liu, Yao Chang; Valenzuela, Rafael; Allen, Carl M.; Bona, S. H.; Larrimer, Nye; Korman, Neil J.

doi:10.1016/0190-9622(92)70220-a

Cited by 122 publications

(68 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although our group 4 and others [5][6][7][8][9][10] have observed PNP manifesting as lichenoid eruptions, this case series suggests that such a presentation may be more common than previously recognized.…”

Section: Commentcontrasting

confidence: 39%

Lichenoid Dermatitis in Paraneoplastic Pemphigus

Bowen¹,

Peters²,

Fivenson³

et al. 2000

Arch Dermatol

View full text Add to dashboard Cite

Section: Commentcontrasting

confidence: 39%

Lichenoid Dermatitis in Paraneoplastic Pemphigus

Bowen¹,

Peters²,

Fivenson³

et al. 2000

Arch Dermatol

View full text Add to dashboard Cite

“…Although steroids alone may result in a response of cutaneous lesions, mucosal or conjunctival lesions are refractory to treatment. Azathioprine has been shown to be slightly efficient [4], and plasmapheresis does not substantially affect the course of PNP [1,10]. Cyclosporine has led to some good responses with longterm effect [5,6].…”

Section: Discussionmentioning

confidence: 99%

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL

et al. 2001

View full text Add to dashboard Cite

Paraneoplastic pemphigus is a severe mucocutaneous disease associated in most cases with B-cell lymphoproliferative disorders. Independent of the course of the underlying malignancy, this autoimmune skin disease is resistant to any treatment in most cases and may lead to death by infectious complications. We observed a patient with recovery of paraneoplastic pemphigus associated with follicular non-Hodgkin's-lymphoma after therapy with rituximab. In addition, we reviewed the literature and analyzed the few cases with comparable outcome with other treatment modalities. Am.

show abstract

“…They are typically composed of variable amounts of stromal and cellular elements, and are benign tumorlike lesions of unknown etiology that can occur at different anatomic sites and have variable non-specific clinical symptoms. Although myofibroblasts were not detected in histopatholgic examination, it is possible that our case would be associated with these tumors [24].…”

Section: Discussionmentioning

confidence: 91%